5:03 PM
 | 
May 24, 2010
 |  BC Extra  |  Company News

FDA accepts vilazodone NDA

FDA accepted an NDA from Clinical Data Inc. (NASDAQ:CLDA) for vilazodone to treat major depressive disorder (MDD). The acceptance...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >